Illumina buying Boulder’s SomaLogic for $350M+
Less than two years after Boulder-based biotech firm SomaLogic Inc. merged with Standard BioTools Inc. (Nasdaq: LAB), Illumina Inc. (NASDAQ: ILMN) has inked a deal to absorb SomaLogic’s business in an acquisition worth as much as $425 million.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
An Austin, Texas-based genetics-testing company that specializes in cell-free DNA and precision medicine has acquired…
-
NewVale Capital LLC recently closed its oversubscribed inaugural fund with $167 million to deploy in…
-
Foresight Diagnostics Inc., a Boulder-based cancer diagnostics company that specialized in the development of ultra-sensitive…
-
BOULDER — Clinical-stage, pre-revenue pharmaceutical company Edgewise Therapeutics Inc. (Nasdaq: EWTX) plans to sell nearly…
